BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Cost of Revenue

Cost of Revenue analysis for CSCI.

Quarterly Cost of Revenue

$1.77M
↑ 16.93% YoY

As of Jun 30, 2025

Annual Cost of Revenue (TTM)

$5.02M
↑ 0.59% YoY

Trailing 12 months ending Jun 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin